Publication | Open Access
Design of Anti-HIV Ligands by Means of Minimal Topological Difference (MTD) Method
14
Citations
10
References
2006
Year
EngineeringComputational ChemistryAntiviral DrugAnti-hiv LigandsMolecular PharmacologyMedicinal ChemistryAntiviral Drug DevelopmentMtd MethodsMolecular SimulationMolecular RecognitionBiophysicsMinimal Topological DifferenceBiochemistryMedicineHept LigandsHivPharmacologyMolecular ModelingMtd MethodRational Drug DesignMolecular DockingDrug Discovery
Molecular modeling and MTD methods are useful tools to assess both qualitative(SAR) and quantitative (QSAR) chemical structure-biological activity relationships. The 1-[(2-hydroxiethoxi)-methyl]-6-(phenylthio)thymine congeners (HEPT ligands) show in vitroanti-viral activity against the type-1 human immunodeficiency virus (HIV-1), which is theetiologic agent of AIDS. This work shows an extensive QSAR study performed upon a largeseries of 79 HEPT ligands using the MTD and HyperChem molecular modeling methods.The studied HEPT ligands are HIV reverse-transcriptase inhibitors. Their geometries wereoptimized and conformational analysis was carried out to build the hypermolecule, whichallowed applying the MTD method. The hypermolecule was used for space mapping of thereceptor’s interaction site. The obtained results show that there are three 3D molecular zonesimportant for the anti-HIV biological activity of the HEPT ligands under study.
| Year | Citations | |
|---|---|---|
Page 1
Page 1